Search
for
Sort by
Research 31–60 of 46
- Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling
- Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022
- Drug repurposing: Clinical practices and regulatory pathways
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Chinese Herbal Medicine, Guilu Erxian Glue, as Alternative Medicine for Adverse Side Effects of Chemotherapy in Doxorubicin-Treated Cell and Mouse Models
- Endocrine effects of long-term calcineurin inhibitor use in solid organ transplant recipients
- Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
- TMT-Based Proteomic Explores the Influence of DHEA on the Osteogenic Differentiation of hBMSCs
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Breast cancer in a transgender man
- Drug-associated gingival disorders: a retrospective pharmacovigilance assessment using disproportionality analysis
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- E-Poster
- How to ‘Google’ in front of the patient: A practical approach to information seeking during the consultation
- Advances in Hair Restoration
- Alopecia areata after denosumab treatment for osteoporosis
- Denosumab-induced alopecia areata with lichenoid eruption
- BH22 Alopecia areata caused by an adverse reaction to denosumab
- Rare Case of Alopecia: Alopecia Neoplastica
- Management of Advanced Prostate Cancer Undergoing Major Shift
- DHEA : why, when, and how much ? D’après la conférence de Bruno Allolio (Wuerzburg), 50e Journées internationales d’endocrinologie clinique Henri-Pierre KLOTZ, septembre 2007
- The North American Menopause Society Recommendations for Clinical Care of Midlife Women
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Androgenic Effects on Ventricular Repolarization
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- A Case of Rhupus with Rowell Syndrome
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- The Influence of Flightless I: Regeneration versus Wound Healing
- Comparison of Mineral Levels in Blood and Hair Samples of Healthy Adults: Evaluating the Clinical Utility of Hair Mineral Analysis